KT-A252

N/A

Report date: 2022/05/10 11:43:20

Base Information

Drug NameKT-A252
Drug Alias NameKTA252
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionComplement activation inhibitorsGene transference
TargetsUpdating
Therapy Area/IndicationsMacular Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMedical University Of South Carolina
China Registration ClassN/A

Develop Information

Active CompaniesMedical University Of South CarolinaKriya Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsMacular Degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A